Amberg and McClure (1) first identified citric acid as a normal excretory product in human urine. Oestberg (2) noted that citrate excretion increased greatly during metabolic alkalosis and decreased during states of acidosis and thus varied with urinary pH. Other investigators (3, 4) demonstrated that factors other than urinary pH also altered the excretion of citric acid. Study of the metabolic pathways of citrate formation and utilization culminated in the classic paper of Krebs and Johnson (5) in which the tricarboxylic acid cycle was first postulated. Krebs included succinate, l-malate, and fumarate as participants in the "cycle." Orten and Smith (6) reported that the intravenous administration of these dicarboxylic acids increased the urinary excretion of citrate, and malonate was also shown to have the same effect. Krebs, Salvin and Johnson (7) extended these experiments, demonstrated that oxaloacetate increased citrate and a-ketoglutarate output in urine, and suggested that malonic acid acted as a succinic dehydrogenase inhibitor rather than as a direct precursor of citric acid in the proposed cycle. No consideration was given to the renal clearance of citrate and the possibility of changes in tubular reabsorption, or of secretion, of this solute as a factor in altered urine citrate output, so that a greatly increased urinary excretion of citrate was accepted as prima facie evidence of increased endogenous production. However, the relative roles of filtration, tubular reabsorption, and secretion, together with the factors that influence them, must be properly evaluated before conclusions are drawn regarding changes in urine citrate output as evidences of its altered metabolism. Herrin Creatinine was given as a priming dose of 500 mg and added in sufficient concentration in the subsequent infusion solution to maintain a serum level of approximately 10 mg per 100 ml. In the experiments investi-1290 gating the effects of acidosis, alkalosis and acetazolamide on renal handling of citrate, a 0.05 M solution of sodium citrate was slowly infused into a peripheral vein, the rate being regulated at 3 ml per minute by a peristaltic action infusion pump. Arterial blood samples were taken every 10 minutes and the citrate clearances determined while the plasma citrate was progressively raised to approximately 20 mg per 100 ml. Metabolic alkalosis and acidosis were effected by intragastric administration of sodium bicarbonate or ammonium chloride solutions during the 24 hour period prior to the experiment.
In the experiments testing the effect of acetazolamide, doses of 50 mg per kg each were given orally 24, 12, and 1 hour before the experiment. In certain of these studies the effect of acetazolamide and concomitant metabolic alkalosis was determined. It was necessary to give two to three times the alkalinizing dose of bicarbonate used in control animals to achieve the same degree of elevation of plasma bicarbonate levels in the animals receiving acetazolamide as in the controls.
Experiments were also performed to test the effect of malic, succinic, and malonic acids on the renal clearances of citrate. These dicarboxylic acids were given by priming the animals with solutions of the sodium salts, supplying 3 mmoles per kg body weight. This was followed by a constant infusion of the sodium salts as a 0.05 M solution at a rate of 3 ml per minute.
Creatinine was measured by the picric acid method as modified by Brod and Sirota (13), citrate as described by Natelson, Pincus and Lugovoy (14) concentrations of serum bicarbonate. In the experiments in which serum bicarbonate concentrations were in the physiological range, citrate was not excreted in the urine in the periods before the intravenous injection of this ion and did not appear until the concentration of citrate in plasma reached 6 to 8 mg per 100 ml. In the metabolic acidosis experiments citrate was not found in the urine until the plasma level was raised to 13 mg per 100 ml, but after induction of metabolic alkalosis, citrate was excreted even at normal plasma concentrations of 2 to 4 mg per 100 ml. The citrate to creatinine clearance ratios were compared in the normal, acidotic and alkalotic states during periods when the plasma citrate concen- tration had been raised to the same level (18 mg per 100 ml). The ratios were approximately 0.3 in the normal state, 0.2 during acidosis and 0.4 during alkalosis. The rate of urine flow during the infusion of citrate was in the same range in the experiments in the bicarbonate-loaded dogs as in the control studies (between 4 to 8 ml per minute). The effect of bicarbonate-induced alkalosis on citrate clearance could not be correlated with urine volume. In one of the acidosis experiments, urine flow was reduced to less than 1 ml per minute but in the second was maintained at over 4 ml per minute. No evidence of a Tm for citrate was seen as the plasma citrate levels were raised to approximately 20 mg per 100 ml. This concurs with the data of Keyl and Lotspeich (9) . who found no Tm for citrate at the highest citrate loads tolerated by the dog.
Effect of acetazolarnide. The clearance of citrate at normal and at elevated plasma concentrations of citrate is illustrated in Figure 2 (21) have develministration resulted in an increased excretion of oped the hypothesis that renal tubular reabsorpcitrate and a-ketoglutarate in urine, although the tion of citrate-is controlled by the pH within reurine pH dropped. The dissociation of urine pH nal tubule cells rather than by urine pH. A and citrate excretion is further shown by the ef-reduced intracellular pH in potassium-deficient fect of acetazolamide, which decreases citrate ex-states could then explain the diminished citrate cretion in rats and man although urine pH is in-clearance which has been found. The alterations creased (19, 20) . In the present experiments, of pH in renal tubule cells are only conjectural so that this hypothesis has not been subjected to any real test. The pH of the renal tubule cell in the alkalotic dog given acetazolamide is unknown.
Vishwakarma and Lotspeich (10) have clearly shown that in the dog, malic acid is secreted by the renal tubules after infusion of citrate, a-ketoglutarate, and succinate. No evidence of tubular secretion of citrate is seen in the data presented here. The citrate clearance becomes approximately equal to, but not greater than, the creatinine clearance when the structurally related organic acids-succinate, malate, and malonateare infused. Increasing the serum and urinary pH by administration of sodium bicarbonate along with these dicarboxylic acids does not affect this maximal clearance in any way. The combination of metabolic alkalosis and elevation of plasma citrate concentration also does not result in citrate clearances greater than the simultaneously measured glomerular filtration rate.
Renal clearance measurements can demonstrate tubular secretion of a solute only if addition of the solute to tubular urine is greater than any reabsorption that may occur. Clearance experiments cannot of themselves, therefore, exclude bidirectional transfer of solute in the renal tubule if reabsorption is equal to, or greater than, the transfer of solute from cell to tubular urine. It is conceivable, then, that fluctuations in citrate excretion under the experimental conditions imposed may result from alterations in the addition of citrate from the cells as well as in the tubular reabsorption of citrate. However, the probability seems greater that the important variable is in tubular reabsorption of citrate. Certainly, none of the procedures pushed citrate excretion beyond the estimated amounts filtered through the glomeruli. The essential coincidence of the citrate and creatinine clearances in a number of experiments in which dicarboxylic acids were injected suggests virtually complete inhibition of tubular reabsorption of citrate by malate, succinate, and malonate which is overcome when the filtered citrate is increased by injection of sodium citrate. This latter phenomenon suggests a competitive mechanism.
Serum citrate levels increase little if at all after the injection of malate or succinate despite the manyfold increase in urine excretion. This also suggests that these dicarboxylic acids increase citrate clearances by competition with this ion for a tubular reabsorptive mechanism rather than by increasing cellular production of citrate through the tricarboxylic acid cycle. Furthermore, the effect of succinate is not reversed by addition of malonate but rather, malonate itself has an effect similar to that of malate and succinate. Finally, we have confirmed the observation of Martensson (22) and Herndon and Freeman (23) that the amount of citrate removed by the kidney is somewhat greater than that calculated to be filtered. This indicates that the citric acid metabolized by the kidneys is not derived solely from that taken up from the tubular lumen. However, after the administration of malate, utilization is decreased by 80 to 90 per cent. There are two possible interpretations of this phenomenon. One is that an increase of malate within the cell inhibits citrate utilization, and the consequent increase in intracellular citrate concentration blocks tubular reabsorption of citrate. An alternative and more probable explanation is that the greatest part of the citrate utilized by the kidneys is obtained from the luminal side of the renal tubular cell by a process of reabsorption which can be competitively inhibited by malate, succinate, or malonate. A small but definite percentage probably diffuses into the tubule cell from the peritubular space by a mechanism that is not affected by the presence of other tricarboxylic acid cycle substrates.
SUMMARY
The effects of acidosis, alkalosis, acetazolamide, and certain organic acids of the tricarboxylic acid cycle on the renal excretion of citric acid in the dog have been investigated by means of standard clearance techniques. Citrate clearances are increased by alkalosis and diminished by acidosis. Tubular reabsorption of citrate is complete at normal serum concentrations in alkalotic, acetazolamide-treated dogs, suggesting that acetazolamide increases the tubular reabsorption of citrate at ordinary filtered loads by a mechanism unrelated to the pH of urine or of plasma.
When plasma citrate concentrations are raised to eight to ten times normal values, the citrate clearances are still less than the glomerular filtration rate even though metabolic alkalosis is super-imposed in an effort to inhibit tubular reabsorption of citrate. The citrate clearances become equal to the creatinine clearances after infusions of sodium l-malate at normal or increased plasma bicarbonate concentrations. Sodium succinate also increases citrate clearances so that they are equal to the filtration rate, and this effect is not influenced by addition of the succinic dehydrogenase inhibitor, malonic acid. During these experiments the concentration of citrate in the plasma remains in the normal range. The intravenous injection of sodium citrate reverses the effect of malate on tubular reabsorption of citrate. The renal utilization of this ion as calculated from renal arteriovenous differences and simultaneous urinary clearance measurements is strikingly inhibited by the injection of l-malate.
These data are consistent with a renal mechanism of citrate excretion involving filtration and reabsorption without tubular secretion. The reabsorption and subsequent utilization of filtered citrate by the tubule cell appear to be competitively inhibited by the tricarboxylic acid cycle substrates -malate and succinate-and also by malonate.
